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Introduction {#sec005}
============

Cardiovascular diseases (CVDs) are leading causes of death in the world in recent decades. Global burden of diseases in 2015 also clearly showed that CVDs remain a major cause of health losses for all regions of the world. Although a dramatic decline in CVD mortality has been seen in regions with very high sociodemographic indexes, but only a gradual decrease or no change has occurred in most regions \[[@pone.0238082.ref001]\]. In these regions, ambient PM~2.5~ contributed the greatest burdens of diseases, which increased over the past 25 years, due to aging population and increasing air pollution in low-income and middle-income countries \[[@pone.0238082.ref002]\]. Numerous studies have provided persuasive evidence that short-term exposure to PM~2.5~ over a period of a few hours to weeks can trigger CVD-related mortality and non-fatal events, especially among susceptible individuals. Susceptible individuals at greater risk may include elderly and obese patients with preexisting coronary artery disease, and chronic metabolic diseases. A systemic review of the American Heart Association (AHA) also specifically demonstrated that the PM~2.5~ concentration-cardiovascular risk relationships for both short- and long-term exposure tend to fall below 15 ug/m^3^ without a recognizable "safe" threshold. Many biological mechanisms have shown PM exposure could exacerbate existing CVDs and trigger acute cardiovascular events (within a few hours) and also addressed the need to investigate ultra-acute peak PM excursions (e.g., 1 to 2 hours), which have been less studied. The time frame of awareness and personal protection in susceptible subjects should be considered in clinical recommendation \[[@pone.0238082.ref003]\].

Many epidemiologic studies have well addressed the concentration-relationship between short-term exposure to PM~2.5~ and cardiovascular events, including ischemic heart disease, heart failure, cardiac arrhythmia/arrest, and ischemic strokes in daily time scales of air pollution. However, only a small number of epidemiological studies have examined the effects of hourly variations in air pollution on triggering CVD events. Intracerebral hemorrhage mortality has been found to be associated with the hourly concentration of suspended particulate matter (1--2 hour lag), according to the Ministry of Health, Labour, and Welfare of Japan \[[@pone.0238082.ref004]\]. A study conducted in Okayama, Japan also found that suspended particulate matter exposure of 0 to \<6 hours before the case events was significantly associated with risks of onset of cardiovascular and cerebrovascular disease in emergency hospital visits \[[@pone.0238082.ref005]\]. One study conducted in the Boston area further found that the increase in risk of ischemic stroke onset was greatest within 12 to 14 hours of exposure to ambient fine particulate matter air pollution \[[@pone.0238082.ref006]\]. However, studies conducted in 8 cities in Ontario \[[@pone.0238082.ref007]\], Houston \[[@pone.0238082.ref008]\], and South London \[[@pone.0238082.ref009]\] do not support the hypothesis that hourly increases in PM~2.5~ levels are associated with CVD events.

Our study used a time-stratified, case-crossover design to assess the associations between hourly changes in PM~2.5~ levels and the risk of cardiovascular disease onset in residents of Tainan City, Taiwan, who had visited emergency rooms in Chi Mei Medical Center between January 2006 and December 2016.

Materials and methods {#sec006}
=====================

Study design and subjects {#sec007}
-------------------------

A time-stratified, case-crossover design was used in this study \[[@pone.0238082.ref010]\]. A case-crossover study can be thought of as a type of self-matched, case control study. For each individual case, exposure before the event (case period) is compared to exposure at other control periods. Hourly hospital admission data (2006--2016) were collected from Chi Mei Medical Center in Tainan City. Patients with cardiovascular diseases (N = 26749) aged ≥20 years old were selected according to the International Classification of Diseases 9^th^ edition, Clinical Modification (ICD-9 CM) codes (428 Heart failure, 426--427 Arrhythmia, 430--438 Cerebrovascular disease, 410--414 and 429 Ischemic heart disease, 440--449 Peripheral vascular disease). We used the time of emergency visit as the onset for each case. Control periods for each case were selected as the same times on other days, on the same days of the week in the same months and years \[[@pone.0238082.ref011]\]. Residential addresses were used to identify the ambient air pollution exposure concentrations from the closest station.

Air pollution data and meteorological data {#sec008}
------------------------------------------

We obtained hourly pollutant concentrations of PM~10~, PM~2.5~, SO~2~, NO~2~, NO, O~3~, CO, total hydrocarbons (THC), and non-methane hydrocarbons (NMHC), and meteorological indices of temperature, relative humidity, and wind speed at 4 air quality monitoring stations (AQMS) of the Taiwan EPA in Tainan City during the study period. Hourly data for each case and control period were collected from the closest station.

Statistical analyses {#sec009}
--------------------

Conditional logistic regression with the stepwise selection method was used to estimate adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the association between air pollutant exposure and emergency visits due to cardiovascular diseases. To fully adjust for the potential time-variant confounders, we used natural cubic splines with 3 degrees of freedom (df) for the ambient temperature, relative humidity and wind speed in all models. All case event periods and cases event periods in PM~2.5~\>10 μg/m^3^, PM~2.5~\>25 μg/m^3^, and PM~2.5~\>54 μg/m^3^ were also identified to assess the effects per 10 μg/m^3^ increases in PM~2.5~. In all analyses, we tested the linearity assumption between air pollution exposure and health outcomes by replacing the continuous exposure variables by a natural spline with 3 degrees of freedom and compared the model fit by the likelihood ratio test. Goodness of fit among different models was assessed by AIC. Collinearity among variables was assessed by VIF. We conducted analyses using the SAS statistical package. This study is approved by the Institutional Review Board of Chi Mei Medical Center on 14^th^ Dec. 2018 (No.10612-012) and is exempt from obtaining inform consent.

Results {#sec010}
=======

All the patients visiting Chi Mei Medical Center with defined vascular disease events were enrolled from Jan. 2006 to Dec. 2016. There were 26,749 cases including 10,310 females (38.5%) and 16,439 males (61.5%) identified during the study period. To explore the threshold effects of different fine particulate matter concentrations, we used 24 hours average PM~2.5~ levels prior to events to classify cases in different exposure backgrounds, 10 μg/m^3^ (WHO annual mean guideline value) and 25 μg/m^3^ (WHO 24-hour mean guideline value). We identified 21,756 cardiovascular cases with PM~2.5~\>10 μg/m^3^ including 8409 females (38.7%) and 13,347 males (61.3%), and 12,524 cases were identified with PM~2.5~\>25 μg/m^3^ including 4,894 females (39.1%) and 7,630 males (60.9%) ([Table 1](#pone.0238082.t001){ref-type="table"}). The demographic characteristics of cases among different background levels were almost constant. Briefly, the patients are predominantly male (60.9--61.5%) and elders (54.6--55.0%), with higher rates of nighttime attacks (65.8--66.0%). Among the cardiovascular diseases, cerebrovascular disease (56.6--57.3%) is the major disease attack, followed by ischemic heart disease (21.9--22.4%), arrhythmia (8.5--8.8%), heart failure (8.0--8.4%) and peripheral vascular disease (4.1--4.3%).

10.1371/journal.pone.0238082.t001

###### Characteristics of hospital emergency visits for patients with cardiovascular disease in a medical center in Tainan City, 2006 to 2016 in different PM~2.5~ ambient backgrounds (24 hours average before emergency visits).

![](pone.0238082.t001){#pone.0238082.t001g}

                                 All cases   PM~2.5~\>10 μg/m^3^   PM~2.5~\>25 μg/m^3^                      
  ------------------------------ ----------- --------------------- --------------------- ---------- ------- ----------
  **Total**                      26749       (100.0%)              21756                 (100.0%)   12524   (100.0%)
  **Gender**                                                                                                
   Female                        10310       (38.5%)               8409                  (38.7%)    4894    (39.1%)
   Male                          16439       (61.5%)               13347                 (61.3%)    7630    (60.9%)
  **Age**                                                                                                   
   \< 65                         12157       (45.4%)               9795                  (45.0%)    5633    (45.0%)
   ≥ 65                          14592       (54.6%)               11961                 (55.0%)    6891    (55.0%)
  **Onset time**                                                                                            
   Daytime (8 am- 7 pm)          9155        (34.2%)               7433                  (34.2%)    4255    (34.0%)
   Nighttime (8 pm- 7 am)        17594       (65.8%)               14323                 (65.8%)    8269    (66.0%)
  **Cardiovascular disease**                                                                                
   Heart failure                 2127        (8.0%)                1760                  (8.1%)     1055    (8.4%)
   Arrhythmia                    2280        (8.5%)                1871                  (8.6%)     1097    (8.8%)
   Cerebrovascular disease       15322       (57.3%)               12345                 (56.7%)    7093    (56.6%)
   Ischemic heart disease        5918        (22.1%)               4881                  (22.4%)    2740    (21.9%)
   Peripheral vascular disease   1102        (4.1%)                899                   (4.1%)     539     (4.3%)

The average air pollutants and meteorological data in both control periods and case periods are presented in [Table 2](#pone.0238082.t002){ref-type="table"}. The average temperature degree (24.71 V.S. 21.14) and relative humidity percentage (75.86% V.S. 68.57%) are higher in control periods. The average wind speed velocity (2.49 m/s V.S. 2.36 m/s) is faster in case periods. The average concentration of pollutants of PM~10~ (126.98 μg/m^3^ V.S. 67.37 μg/m^3^), PM~2.5~ (48.6 μg/m^3^ V.S. 25.8 μg/m^3^), NO~2~ (19.69 ppb V.S. 14.49 ppb), NO (3.64 ppb V.S. 3.37 ppb), SO~2~ (5.4 ppb V.S. 30.15 ppb), CO (0.54 ppb V.S. 0.4 ppb), and O~3~ (36.39 ppb V.S. 14.49 ppb) are all higher in case periods.

10.1371/journal.pone.0238082.t002

###### Twenty-four hours average air pollutants and meteorological data in case periods and control periods.

![](pone.0238082.t002){#pone.0238082.t002g}

  Species                 Unit      Control periods   Case periods            
  ----------------------- --------- ----------------- -------------- -------- -------
  **Temperature**         degree    24.71             5.22           21.14    5.01
  **Relative Humidity**   \%        75.86             11.25          68.57    13.25
  **Wind Speed**          m/s       2.36              1.32           2.49     1.39
  **PM**~**10**~          μg/m^3^   67.37             39.01          126.98   97.66
  **PM**~**2.5**~         μg/m^3^   25.8              18.61          48.6     39.6
  **NO**~**2**~           ppb       14.49             8.34           19.69    8.92
  **NO**                  ppb       3.37              4.58           3.64     5.01
  **SO**~**2**~           ppb       3.77              2.23           5.4      2.7
  **CO**                  ppm       0.4               0.2            0.54     0.2
  **O**~**3**~            ppb       30.15             22.37          36.39    25.05

The odds ratio (OR) of vascular disease events and PM~2.5~ was first assessed by a single-pollutant model ([Fig 1](#pone.0238082.g001){ref-type="fig"}). Odds ratios of cardiovascular emergency visits with 10 μg/m^3^ increases in PM~2.5~ at 0 to 48 hours before disease onset were all statistically significant when including all cases in the model.

![Odds ratio of cardiovascular emergency visits for 10 μg/m^3^ increase in PM~2.5~ based on the time weighted average before disease onset by using single-pollutant logistic regression in different PM~2.5~ case periods.](pone.0238082.g001){#pone.0238082.g001}

The lag--response relationship increased slightly with cumulative exposure before the case event from 0 to 48 hours in all cases. When we only include cases occurring with PM~2.5~\>10 μg/m^3^ and PM~2.5~\>25 μg/m^3^, very significant ORs could be observed for 10 μg/m^3^ increases in PM~2.5~ at 0 and 1 hour, implying fine particulate exposure could promptly trigger vascular disease events. Moreover, a very clear increased risk level could be observed with cumulative exposure from 0 to 48 hours, especially in those cases identified when PM~2.5~\>25 μg/m^3^.

The linear model and non-linear model were assessed under the linearity assumption and goodness of fit between air pollution exposure and health outcomes. In comparison with the non-linear model, the linear model presented a better goodness of fit and collinearity in the relationship between OR and 1-hour PM~2.5~ concentration before emergency visits due to vascular events ([Fig 2](#pone.0238082.g002){ref-type="fig"}). Considering applicability for air quality management, the linear model for cardiovascular disease is used to build a multi-pollutant model. Multivariate logistic regression model was used to examine the short-term effects (1 hour exposure before emergency visit) of PM~2.5~ and emergency visits in cases occurring with PM~2.5~\>10 μg/m^3^ and PM~2.5~\>25 μg/m^3^. Adjusted OR per 10 μg/m^3^ increase in PM~2.5~ at 1 hour before the emergency visit was higher in PM~2.5~\>25 μg/m^3^ (OR = 1.06, 95% C.I. 1.03--1.09) compared to those cases occurring at PM~2.5~\>10 μg/m^3^ (OR = 1.03, 95% C.I. 1.02--1.04). Stratifying onset of those cases at daytime and nighttime by using multivariate models showed higher ORs per 10 μg/m^3^ increase in PM~2.5~ in cases onset at nighttime both could be found when PM~2.5~\>10 μg/m^3^ and PM~2.5~\>25 μg/m^3^. The ORs of vascular disease statistically increased in both age groups (age≧65 and age\<65), for males, and for daytime and nighttime admission when PM~2.5~\>10 μg/m^3^ ([Fig 3A](#pone.0238082.g003){ref-type="fig"}). Although the ORs increased when PM~2.5~\>25 μg/m^3^ after adjustment, the risk only significantly increased in age≧65 y/o, males, females, and for night time admissions ([Fig 3B](#pone.0238082.g003){ref-type="fig"}). The adjusted ORs per 10 μg/m^3^ increase in PM~2.5~ of different vascular diseases were also examined. After adjustment of multiple pollutants and meteorological indices, risk of cerebrovascular disease onset increased constantly and significantly for both PM~2.5~\>10 μg/m^3^ and PM~2.5~\>25 μg/m^3^ ([Fig 4](#pone.0238082.g004){ref-type="fig"}).

![Relationship between odds ratio and 1-hr PM~2.5~ concentrations before emergency visits.\
(A) Linear model, (B) Non-linear model.](pone.0238082.g002){#pone.0238082.g002}

![Adjusted ORs per 10 μg/m^3^ increase in PM~2.5~ at 1 hour before emergency visits for different ages, genders and periods of emergency visits.\
(A) PM~2.5~\>10 μg/m^3^ with model adjusted for ambient temperature, humidity, wind speed, and ozone; (B) PM~2.5~\>25 μg/m^3^ with model adjusted for ambient temperature, relative humidity, wind speed, PM~10~, CO, and ozone.](pone.0238082.g003){#pone.0238082.g003}

![Adjusted ORs per 10 μg/m^3^ increase in PM~2.5~ at 1 hour before emergency visits in different types of cardiovascular diseases.\
(A) PM~2.5~\>10 μg/m^3^ with model adjusted for ambient temperature, humidity, wind speed, and ozone, (B) PM~2.5~\>25 μg/m^3^ with model adjusted for ambient temperature, relative humidity, wind speed, PM~10~, CO, and ozone.](pone.0238082.g004){#pone.0238082.g004}

Discussion {#sec011}
==========

Our study results show that the OR of vascular event onset was elevated immediately with current hour PM~2.5~ levels, implying fine particulate exposure could promptly trigger vascular disease event. We also observed that elevated risk persisted from 0 to 48 hours in both PM~2.5~ thresholds of the WHO long-term guideline value 10 μg/m^3^ and the WHO 24-hour mean guideline value of 25 μg/m^3^. The relationship between risk of onset of vascular event and short-term PM~2.5~ levels tend to reveal a linear concentration response function. Compared to other type of vascular diseases, cerebrovascular disease was more strongly associated with PM~2.5~ levels in Tainan City.

The transient response of elevated risk of fine particles (PM~2.5~) to vascular disease events in our study was consistent with previous studies applying hourly data analysis. Our study not only shows the transient risk of PM~2.5~ in triggering vascular disease events, but also indicates continuously elevated risk for cumulative exposure of 48 hours. A study conducted in the Boston area showed that hourly PM~2.5~ was associated with transient risk of acute myocardial infarction (AMI) onset (2 hours before onset). An elevated risk of MI was also found in 24-hour average PM~2.5~ concentrations \[[@pone.0238082.ref012]\]. Another study also conducted in the Boston area found that OR of acute cerebrovascular diseases and ischemic strokes elevated immediately, and peaked in association with mean PM~2.5~ levels 12 to 14 hours earlier and decreased thereafter \[[@pone.0238082.ref006]\]. A study conducted in southern Germany using traffic exposure as an indicator of fine particle and other traffic-related pollution also found the highest risk at onset of AMI within one hour after traffic exposure \[[@pone.0238082.ref013]\]. A further study also demonstrated that elevated risk persisted for up to 6 hours. The data suggested that transient exposure to traffic regardless of the means of transportation may increase the risk of AMI transiently. One study analyzing data of acute coronary syndrome patients treated at the University of Rochester Medical Center (URMC) Cardiac Catheterization Laboratory, with ambient air pollutant concentrations measured in Rochester, New York, by case-crossover methods, also found significant increases in the risk of acute coronary syndromes associated with each 7.1 μg/m^3^ increase of PM~2.5~ concentration in the 1 hour prior to acute coronary syndrome attack \[[@pone.0238082.ref014]\]. These increase in transient risks immediately after fine particle exposure are supported by many human exposure studies and these findings demonstrate that inhalation of ambient PM~2.5~ causes rapid changes in nocturnal heart rate variability (25 minutes exposure) and acute conduit artery vasoconstriction (2 hours inhalation) \[[@pone.0238082.ref015], [@pone.0238082.ref016]\]. Experimental studies testing diesel exhaust inhalation have also demonstrated acute vascular dysfunction, ischemia, and thrombotic dysfunction within a few hours of exposure \[[@pone.0238082.ref017]--[@pone.0238082.ref020]\]. Our findings confirm that many potential biological mechanisms of PM~2.5~ exposure could exacerbate existing CVDs and trigger acute vascular events. Higher ORs could be observed in those cases with event onset at night in our study. This further supports the view that a few hours of cumulative exposure during daytime (with higher traffic and industrial activities) increases the risk of triggering vascular events night.

Lisabeth et al. studied the data from the population-based Brain Attack Surveillance in Corpus Christi (BASIC) Project and found a borderline significant association between one-day PM~2.5~ and O~3~ exposure and ischemic stroke/TIA risk even in a community with relatively low pollutant levels with median PM~2.5~ of 7.0 μg/m^3^ \[[@pone.0238082.ref021]\]. O'Donnell et al. conducted a study Ontario, Canada, but did not find the association between short-term increase in PM~2.5~ levels and ischemic stroke risk overall by using the average of the values available from all stations by hour in studied areas. However, they found the association between PM~2.5~ and ischemic stroke risk due to large artery atherosclerosis and small vessel disease \[[@pone.0238082.ref007]\]. Our study demonstrated that cerebrovascular disease accounts for the largest portion and most significant vascular disease event after PM~2.5~ exposure. In comparison with the study mentioned above, our study is more informative because we applied hourly pollutant concentrations and meteorological indices from the station nearest to the event case, which provides more representative exposure data than the average data applied in O'Donnell's study and higher ambient PM~2.5~ exposure concentration of 10 μg/m^3^ than that in Lisabeth's study.

Based on the findings from previous studies and our study, cerebrovascular disease is the most significant associated vascular disease in short-term and low concentrations of ambient PM~2.5~ exposure. This phenomenon was found especially in large artery atherosclerosis and small vessel disease stroke patients \[[@pone.0238082.ref007]\]. Besides atherosclerosis, PM~2.5~ probably could also trigger cerebrovascular disease by small vessel occlusion mechanisms. Some plausible mechanisms have been studied and reviewed. O'Neill et al. found that ambient PM~2.5~ exposure is positively associated with vascular cell adhesion molecule 1 (VCAM-1) in type II Diabetes Mellitus patients, suggesting inflammatory response in vascular disease development \[[@pone.0238082.ref022]\]. Wellenius et al. found that exposure to PM~2.5~ with 3.0 μg/m^3^ interquartile range increase was associated with higher resting cerebrovascular resistance and lower cerebral blood flow velocity without significant change in resting mean arterial pressure \[[@pone.0238082.ref023]\]. Furthermore, these changes did not differ significantly among participants with diabetes mellitus, hypertension, smoking, or by sex or season. These results were compatible with our findings that risk increases even with minimal ambient PM~2.5~ level increases, regardless of sex or age.

There are some vascular effects after short-term ambient air pollution exposure which could be possibly correlated with the cerebrovascular vessels including raising arterial blood pressure, increased vascular resistance, and decreased small-vessel elasticity \[[@pone.0238082.ref005], [@pone.0238082.ref007], [@pone.0238082.ref021], [@pone.0238082.ref024]--[@pone.0238082.ref027]\]. These findings could be related to attenuation of the endothelium-dependent vascular dilatation response after air pollutant \[[@pone.0238082.ref012], [@pone.0238082.ref028]\] exposure by affecting NO release \[[@pone.0238082.ref029], [@pone.0238082.ref030]\]. Moreover, the resting cerebral blood flow velocity is lower in patients with diabetes mellitus microvascular complications and has been shown to be correlated with systemic arterial stiffness \[[@pone.0238082.ref006], [@pone.0238082.ref031]\]. Lower cerebral blood flow velocity and arterial stiffness could lead to risk of vascular occlusion, which in part explains our findings related to stroke risk increment. However, the exact mechanisms need to be further verified in more detailed clinical study.

The systemic review of epidemiological studies of PM~2.5~ concentration-cardiovascular risk relationships for both short- and long-term exposures points a monotonic increasing function. The elevated risk was found to extend below 15 μg/m^3^ without a discernable "safe" threshold \[[@pone.0238082.ref003]\]. Our study found that the association between PM~2.5~ level 1 hour before emergency visit and risk of vascular disease onset showed a monotonic linear function. This finding was also found in the Boston area according to US National Ambient Air Quality Standards, with approximately linear association between PM~2.5~ level and risk of ischemic stroke onset. These results suggest that PM~2.5~ exposure increases the risk of ischemic stroke event sat levels below those currently considered safe under US regulations \[[@pone.0238082.ref006]\]. The US, Taiwan, and many countries of the world have standard regulations for 24-hour and annual average concentrations and do not address transient elevations (minutes to hours) in fine-particle concentration. Our study further used WHO air quality guideline values, 10 μg/m^3^ (annual mean) and 25 μg/m^3^ (24-hour mean), to select our cases for different background levels to estimate the time course of the association between PM~2.5~ levels and vascular disease event onset. Immediate increases in OR for vascular events and elevation of OR following cumulative exposure could even be observed in those cases using the 10 μg/m^3^ threshold, which implies the safe threshold of transient exposure for vascular disease events could fall below 15 μg/m^3^. This finding points to the importance of implementing various strategies to reducing daily individual exposures, especially for those populations at high risk (e.g., the elderly, and individuals with preexisting coronary artery diseases, metabolic syndrome or multiple risk factors, or diabetes). Moreover, public health benefits could be gained from lowering PM~2.5~ concentrations even below the present common standards.

Ambient levels of fine particulate vary seasonally, day to day, at different times of day, and in different microenvironments. Studies conducted in urban building environment also demonstrate vertical and horizontal differences \[[@pone.0238082.ref032], [@pone.0238082.ref033]\]. Individuals have to be able to anticipate when and where pollutant levels are likely to vary in order to mitigate personal health risks. An early warning system or real-time alerts of transient elevations in fine particle levels for protecting the most susceptible population could be considered as national or regional adaptations for public health. Multi-media alerts could also facilitate communication by using mobile phones and personal wearable technology in current time. A study conducted in Canada evaluating the impacts of a phone warning and advising system for individuals vulnerable to smog showed that they are more likely to adopt the recommended behaviors than are non-vulnerable individuals \[[@pone.0238082.ref034]\]. An online survey investigated the frequency at which American health professionals talk about limiting air pollution exposure for patients with respiratory or cardiovascular diseases. Only 34% of respondents, corresponding to 16% of overall health providers, reported talking with their patients with respiratory or cardiovascular disease diagnoses. This suggests a high degree of opportunities for improving awareness about strategies to limit air pollution exposure among vulnerable individuals and their healthcare providers \[[@pone.0238082.ref035]\]. Media alerts of the air quality index have long been recognized as an effective strategy to inform people with asthma and the general public to reduce or change their outdoor activities and thus avoid unhealthy or harmful effects \[[@pone.0238082.ref036], [@pone.0238082.ref037]\]. For better understanding awareness of air quality alerts and specific actions taken, especially by at-risk individuals, a Consumer Styles survey was conducted to analyze 12,599 US adults with self-reported asthma, emphysema/chronic obstructive pulmonary disease, and heart disease, for each aspect of air quality awareness. Respondents with respiratory diseases showed higher levels of air quality awareness and behavior to reduce air pollution exposure. However, patients with heart diseases were not associated with higher levels of air quality awareness. These findings suggest important opportunities to raise the awareness of air quality alerts and promote behavior changes to reduce air pollution exposure, especially for those patients with CVD and also patients without CVD who are at high risk \[[@pone.0238082.ref035]\]. After reviewing 21 studies, D'Antoni found that actual adherence to health advice accompanying air quality warning systems was associated with several psychosocial factors such as knowledge on where to check air quality indices, beliefs that one's symptoms were due to air pollution, perceived severity of air pollution, and advice received from health care professionals \[[@pone.0238082.ref038]\]. Prevision and warning information delivery to make people aware and positive responses to potential health events should be emphasized along with technical and complex information collection methods \[[@pone.0238082.ref039]\]. Most of the ambient pollutant warning systems offering health advice according to epidemiological evidence are categorized by levels, indexes, or bands, which vary from country or country to offer. From the experiences of the Air Pollution Warning System in Quebec, the thresholds of warning systems vary in different areas and seasons according to the mortality data and need to be verified \[[@pone.0238082.ref040]\]. Recently, a newly recommended AQI was lunched in the United Kingdom \[[@pone.0238082.ref039]\]. According this AQI, a 'Low' band suggests that 24 hour PM~2.5~ levels of 1--3 (0--11 μg/m^3^, 12--23 μg/m^3^ and 24--35 μg/m^3^) are unlikely to lead to adverse effects of short-term exposure. Both susceptible and general people can enjoy their activities as usual. The susceptible adults and children with lung and cardiac problems with symptoms should reduce their activities, especially outdoors, when the 24 hour PM~2.5~ level \> = 36 μg/m^3^ reaches the moderate band/index 4 or above. The ambient air quality monitoring systems are well set up in Taiwan. The monitoring system presents real-time AQI from local AQIM stations and forecasts daily AQI to the public for reference. Policies are in place to monitor programs and continuously revise guidance for local and national regulatory policies by regularly monitoring health events, providing warnings and setting up delivery systems to instruct vulnerable people to avoid high concentrations of ambient PM~2.5~ exposure so as to prevent vascular disease events. According to our study results, the risk of vascular disease events increases at levels as low as PM~2.5~ \>10 μg/m^3^ with short time lag of just one hour after ambient PM~2.5~ exposure. We strongly recommend that susceptible people be made aware of the potential risk of acute vascular events and take protection action when the ambient PM~2.5~ \>10 μg/m^3^, such as tight blood pressure control, and good medication compliance.

In summary, our study demonstrated that transient and low concentrations of ambient PM~2.5~ trigger adult vascular disease events, especially cerebrovascular disease, regardless of age, sex, and exposure timing. Warning and delivery systems should be set up to protect people from these prompt adverse health impacts.
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1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes
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2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.
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Reviewer \#1: I found some merits in this methodology, the results obtained are interesting and deserve to be disclosed, as they could provide useful information to policymakers. The topic exposed is in compliance with the arguments required in this journal and the format is respected too. The statistical analysis performed is good and I find the application in this field original. However, I suggest improving the environmental aspect of air quality in big cities adds some specific works to make this work more complete. I suggest you some papers about it:

-Row 302 add: "Analysis of vertical profile of particulates dispersion in function of the aerodynamic diameter at a

congested road in Catania"

-Row 318 add: "Evaluation of the air pollution in a Mediterranean region by the air quality index"

-Row 326 add: "Air quality data for Catania: analysis and investigation case study 2012-2013"

If you improve the weakness of this theme, this manuscript will deserve to be published in this journal.
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1\. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

Response: We added the statement about the waiving inform consent approval information "This study is approved by the Institutional Review Board of Chi Mei Medical Center on 14th Dec. 2018 (No.10612-012) and is exempt from obtaining inform consent." in line 122-4.

\<\<Response to Reviewer \#1\>\>

1\. Reviewer \#1: I found some merits in this methodology, the results obtained are interesting and deserve to be disclosed, as they could provide useful information to policymakers. The topic exposed is in compliance with the arguments required in this journal and the format is respected too. The statistical analysis performed is good and I find the application in this field original. However, I suggest improving the environmental aspect of air quality in big cities adds some specific works to make this work more complete. I suggest you some papers about it:

-Row 302 add: "Analysis of vertical profile of particulates dispersion in function of the aerodynamic diameter at acongested road in Catania"

-Row 318 add: "Evaluation of the air pollution in a Mediterranean region by the air quality index"

-Row 326 add: "Air quality data for Catania: analysis and investigation case study 2012-2013"

Response: Thanks for reviewer's comments and suggestions. We add a sentence "Studies conducted in urban building environment also demonstrate vertical and horizontal differences\[32, 33\]." at row 303-304 and cite more articles \[36, 37\] at row 320 to enrich our manuscript.
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